SLC4A11 Antibody

說明書

中文名稱：

SLC4A11兔多克隆抗體
貨號：

CSB-PA001069
規格：

￥1090
圖片：
Western Blot analysis of K562 cells using BTR1 Polyclonal Antibody

Western Blot analysis of K562 cells using BTR1 Polyclonal Antibody
其他：

產品詳情
產品評價
相關產品
靶點詳情

產品詳情

Uniprot No.：

Q8NBS3
基因名：

SLC4A11
別名：

Bicarbonate transporter related protein 1 antibody; Bicarbonate transporter-related protein 1 antibody; BTR1 antibody; CDPD antibody; CHED2 antibody; Corneal endothelial dystrophy 2 autosomal recessive antibody; dJ794I6.2 antibody; FECD4 antibody; MGC126418 antibody; MGC126419 antibody; NaBC1 antibody; S4A11_HUMAN antibody; Slc4a11 antibody; Sodium bicarbonate transporter-like protein 11 antibody; Sodium borate cotransporter 1 antibody; Sodium coupled borate cotransporter 1 antibody; Solute carrier family 4 member 11 antibody; Solute carrier family 4 sodium bicarbonate transporter like member 11 antibody; Solute carrier family 4 sodium borate transporter member 11 antibody
宿主：

Rabbit
反應種屬：

Human
免疫原：

Synthesized peptide derived from the Internal region of Human BTR1.
免疫原種屬：

Homo sapiens (Human)
標記方式：

Non-conjugated
抗體亞型：

IgG
純化方式：

The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
濃度：

It differs from different batches. Please contact us to confirm it.
保存緩沖液：

Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
產品提供形式：

Liquid
應用范圍：

WB, ELISA

推薦稀釋比：

Application	Recommended Dilution
WB	1:500-1:2000
ELISA	1:20000

Protocols：

Western Blotting (WB) Protocol
ELISA Protocol
儲存條件：

Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
貨期：

Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
用途：

For Research Use Only. Not for use in diagnostic or therapeutic procedures.

產品評價

靶點詳情

功能：

Multifunctional transporter with an impact in cell morphology and differentiation. In the presence of borate B(OH)4(-), acts as a voltage-dependent electrogenic Na(+)-coupled B(OH)4(-) cotransporter controlling boron homeostasis. At early stages of stem cell differentiation, participates in synergy with ITGA5-ITGB1 and ITGAV-ITGB3 integrins and BMPR1A to promote cell adhesion and contractility that drives differentiation toward osteogenic commitment while inhibiting adipogenesis. In the absence of B(OH)4(-), acts as a Na(+)-coupled OH(-) or H(+) permeable channel with implications in cellular redox balance. Regulates the oxidative stress response in corneal endothelium by enhancing antioxidant defenses and protecting cells from reactive oxygen species. In response to hypo-osmotic challenge, also acts as water permeable channel at the basolateral cell membrane of corneal endothelial cells and facilitates transendothelial fluid reabsorption in the aqueous humor. In the presence of ammonia, acts as an electrogenic NH3/H(+) cotransporter and may play a role in ammonia transport and reabsorption in renal Henle's loop epithelium.
基因功能參考文獻：
1. Based on these findings, we infer that high SLC4A11 expression is an independent predictor for poor OS in grade 3/4 serous ovarian cancer. Both DNA amplification and hypomethylation contribute to its upregulation in ovarian cancer PMID: 29091960
2. A missense SLC4A11 mutation (Leu843Pro) is responsible for CHED2 in this family; this is the first report of this mutation in a homozygous state. PMID: 27057589
3. for the first time, compound heterozygous SLC4A11 mutations impair protein function leading to delayed onset of the disease. PMID: 27609159
4. These complex ion transport properties need to be addressed in the context of corneal endothelial disease processes caused by mutations in SLC4A11. PMID: 27581649
5. A role of human SLC4A11 in bicarbonate or borate transport. PMID: 27558157
6. Slc4a11 is an ideally selective H(+)/OH(-) conductive pathway. PMID: 27681179
7. SLC4A11 rs3810560 polymorphism independently affected the sustained viral response rates in chronic hepatitis C patients treated with PEGIFN2b/ribavirin/combination. PMID: 26750805
8. Analysis of SLC4A11, ZEB1, LOXHD1, COL8A2 and TCF4 gene sequences in a multi-generational family with late-onset Fuchs corneal dystrophy found no evidence for found polymorophisms causing the disease in this specific pedigree. PMID: 27121161
9. study reports a newly identified mutation (c.2024A>C) in the SLC4A11 gene segregating with the diseased haplotype in two consanguineous Pakistani families PMID: 26286922
10. we report posterior polymorphous corneal dystrophy resulting from a de novo mutation in ZEB1. Additionally, we present a congenital hereditary endothelial dystrophy case with a thin Descemet membrane with a novel compound heterozygous SLC4A11 mutation. PMID: 26619383
11. we review the current knowledge on the role of the SLC4A11 gene, protein, and its mutations in the pathophysiology and clinical presentation of CHED. [review] PMID: 26451371
12. We report a novel nonsense mutation of the SLC4A11 gene in the patient with CHED2. In addition, one of heterozygous carriers in this family showed features of late onset Fuchs endothelial corneal dystrophy. PMID: 24502824
13. SLC4A11 mutations contribute to 11% (5/45) of sporadic late-onset Late-onset Fuchs endothelial corneal dystrophy (FECD) in the cohort studied. PMID: 25007886
14. SLC4A11 is a novel NH3/H+ co-transporter. PMID: 26018076
15. We found that cells containing mutant SLC4A11 are more vulnerable to oxidative and mitochondrial damage, less able to overcome oxidative stress through the expression of sufficient levels of antioxidant genes, and are more prone to apoptotic death. PMID: 25811729
16. In contrast to the Slc4a11(-/-) mouse, no abnormalities in daily renal ion excretion or polyuria were observed in the Harboyan syndrome patient. PMID: 25500497
17. Potential therapeutic agents to improve the functional impairment of specific SLC4A11 mutant transporters. PMID: 25394471
18. We have described three affected siblings from a non-consanguineous family with Corneal Endothelial Dystrophy 2. PMID: 25138764
19. Our observations suggest that congenital hereditary endothelial dystrophy caused by homozygous SLC4A11 mutations progresses to Harboyan syndrome, but the severity of this may vary considerably. PMID: 24351571
20. Variation in the COL8A2, SLC4A11, and ZEB1 genes is present in only a small fraction of African American cases and as such does not appear to significantly contribute to the genetic risk of Fuchs endothelial corneal dystrophy. PMID: 24348007
21. Data shows that the function of SLCA11 is to facilitate the movement of water across the basolateral corneal epithelium. PMID: 23813972
22. To the best of our knowledge, this is the first Korean case of CHED2, confirmed by the c.1239C>A (p.C413*) mutation in the SLC4A11 gene, which has not been previously reported. PMID: 23615275
23. SLC4A11 has significant EIPA-sensitive Na(+)-OH(-)(H(+)) and NH4(+) permeability. PMID: 23864606
24. The purpose of this study was to identify the genetic cause of congenital hereditary endothelial dystrophy 2 in six Indian families and catalog all known mutations in the SLC4A11 gene. PMID: 23922488
25. Both substitution c.214+242C > T in IL1RN and novel deletion c.2558+149_2558+203del54 in SLC4A11 were observed significantly more frequently in family members with keratoconus. PMID: 23462747
26. SLC4A11 is necessary for cell survival and may explain the pathologic corneal endothelial cell loss in endotheliopathies due to SLC4A11 mutations. PMID: 22447871
27. The reduction in movement of WT SLC4A11 protein to the cell surface caused by Fuchs endothelial corneal dystrophy SLC4A11 helps to explain the dominant inheritance of this disorder. PMID: 22072594
28. biochemical study of SLC4A11 PMID: 21288032
29. The present study detected one novel and three reported changes, adding to the repertoire of mutations in SLC4A11, and recorded a high degree of genetic heterogeneity in Congenital Hereditary Endothelial Dystrophy. PMID: 21203343
30. sequenced SLC4A11 in 192 sporadic and small nuclear late-onset Fuchs corneal dystrophy families and found seven heterozygous missense novel variations that were absent from ethnically matched controls PMID: 20848555
31. Corneal endothelial cells are more vulnerable to defects in the functional activity of SLC4A11 than cells of the striae vascularis of the inner ear. PMID: 20118786
32. The corneal dystrophy and perceptive deafness (Harboyan syndrome) gene (CDPD1) maps to chromosome 20p13. PMID: 11836359
33. describe seven different mutations in the SLC4A11 gene in ten families with autosomal recessive congenital hereditary endothelial dystrophy PMID: 16767101
34. These results confirm that mutations in the SLC4A11 gene cause autosomal recessive corneal endothelial dystrophy. PMID: 16825429
35. These findings extend the implication of the SLC4A11 borate transporter beyond corneal dystrophy to perceptive deafness. PMID: 17220209
36. Novel indel mutation, c.859_862delGAGAinsCCT (E287fsX21) in exon 8 of SLC4A11 gene. Novel in-frame deletion mutation c.2014_2016delTTC or 2017_2019delTTC which will lead to loss of a phenylalanine residue at position 672 or 673 (F672del or F673del). PMID: 17262014
37. report of seven novel mutations and two previously identified mutations in families from India and the United Kingdom with recessive congenital hereditary endothelial dystrophy PMID: 17397048
38. CHED2 (congenital hereditary endothelial dystrophy) is associated with mutations in SLC4A11, a member of the SLC4 family of base transporters. PMID: 17667634
39. These data add to the mutational repertoire of SLC4A11 and establish the high degree of mutational heterogeneity in autosomal recessive congenital hereditary endothelial dystrophy. PMID: 17679935
40. SLC4A11 mutations in Fuchs' endothelial corneal dystrophy are reported. PMID: 18024964
41. A novel SLC4A11 mutation (Thr271Met) is associated with autosomal recessive congenital hereditary endothelial dystrophy in a pedigree from the Kingdom of Saudi Arabia and provides additional support that mutations in this gene cause disease. PMID: 18363173
42. This study increases the number of SLC4A11 gene mutations and confirms the role of this gene in causing congenital hereditary endothelial dystrophy (CHED2). PMID: 18474783
43. In this small cohort, no evidence was found of genetic heterogeneity in congenital hereditary endothelial dystrophy (CHED) and that loss of BTR1 function is the most likely mutational mechanism. PMID: 19369245
顯示更多

收起更多
相關疾病：

Corneal dystrophy and perceptive deafness (CDPD); Corneal endothelial dystrophy (CHED); Corneal dystrophy, Fuchs endothelial, 4 (FECD4)
亞細胞定位：

Cell membrane; Multi-pass membrane protein. Basolateral cell membrane; Multi-pass membrane protein.
蛋白家族：

Anion exchanger (TC 2.A.31) family
組織特異性：

Widely expressed. Highly expressed in kidney, testis, salivary gland, thyroid, trachea and corneal endothelium. Not detected in retina and lymphocytes.; [Isoform 3]: Expressed in corneal endothelium (at protein level).; [Isoform 5]: The predominant isofor
數據庫鏈接：

HGNC: 16438

OMIM: 217400

KEGG: hsa:83959

STRING: 9606.ENSP00000369399

UniGene: Hs.105607

Most popular with customers

YWHAG Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
YWHAB Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC, IF, FC

Species Reactivity: Human, Mouse, Rat
Phospho-YAP1 (S127) Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
XRCC5 Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC, IF

Species Reactivity: Human
XPNPEP1 Recombinant Monoclonal Antibody

Applications: ELISA, IHC, FC

Species Reactivity: Human
XDH Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
WDR5 Recombinant Monoclonal Antibody

Applications: ELISA, IHC, FC

Species Reactivity: Human
VIM Recombinant Monoclonal Antibody

Applications: ELISA, IHC, IF

Species Reactivity: Human